Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 4.460
+0.620 (16.15%)
Apr 10, 2026, 5:07 PM CET
STO:MAGLE Revenue
In the year 2025, Magle Chemoswed Holding AB had annual revenue of 287.55M SEK with 19.53% growth. Magle Chemoswed Holding AB had revenue of 76.03M in the quarter ending December 31, 2025, a decrease of -14.54%.
Revenue
287.55M
Revenue Growth
+19.53%
P/S Ratio
0.32
Revenue / Employee
2.00M
Employees
140
Market Cap
92.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 287.55M | 46.98M | 19.53% |
| Dec 31, 2024 | 240.57M | 69.07M | 40.27% |
| Dec 31, 2023 | 171.50M | 23.51M | 15.89% |
| Dec 31, 2022 | 147.98M | 15.84M | 11.98% |
| Dec 31, 2021 | 132.15M | -10.19M | -7.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IRLAB Therapeutics AB | 57.46M |
| Alzinova AB | 26.80M |
| Scandinavian ChemoTech AB | 12.29M |
| Biovica International AB | 10.93M |
| AcouSort AB | 10.43M |
| Spago Nanomedical AB | 4.82M |
| OncoZenge AB | 2.78M |
| Simris Group AB (PUBL) | 1.62M |